Ronald E. Verrall

University of Saskatchewan — Canada

Chemistry · Physical Sciences

46h-index5.7kcitations175works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Surfactants and Colloidal Systems(66), Thermodynamic properties of mixtures(41), Photochemistry and Electron Transfer Studies(31), Spectroscopy and Quantum Chemical Studies(26), Chemical and Physical Properties in Aqueous Solutions(26)

Publications175 total

Inclusion Complexes of Melphalan with Gemini-Conjugated β-Cyclodextrin: Physicochemical Properties and Chemotherapeutic Efficacy in In-Vitro Tumor Models
Pharmaceutics·2019· 10 citedOpen Access
Design and Evaluation of Gemini Surfactant-Based Lipoplexes Modified with Cell-Binding Peptide for Targeted Gene Therapy in Melanoma Model
Journal of Pharmacy & Pharmaceutical Sciences·2018· 8 citedOpen Access
Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants
Bioconjugate Chemistry·2018· 11 cited
Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model
Pharmaceutical Research·2017· 13 cited
Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models
International Journal of Nanomedicine·2016· 15 citedOpen Access
Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity
The AAPS Journal·2016· 30 cited
Lysine-functionalized nanodiamonds as gene carriers: development of stable colloidal dispersion for in vitro cellular uptake studies and siRNA delivery application
International Journal of Nanomedicine·2016· 36 citedOpen Access
A <sup>1</sup>H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant
Molecular Pharmaceutics·2015· 26 cited
Development of Amino Acid Substituted Gemini Surfactant-Based Mucoadhesive Gene Delivery Systems for Potential use as Noninvasive Vaginal Genetic Vaccination
Nanomedicine·2015· 27 cited
A volumetric and NMR study of cyclodextrin-inhalation anesthetic complexes in aqueous solutions
Canadian Journal of Chemistry·2015· 8 cited
Impact of phospholipids on plasmid packaging and toxicity of gemini nanoparticles
Journal of Materials Chemistry B·2015· 8 citedOpen Access
Characterization of the host&ndash;guest complex of a curcumin analog with &beta;-cyclodextrin and &beta;-cyclodextrin&ndash;gemini surfactant and evaluation of its anticancer activity
SHILAP Revista de lepidopterología·2015Open Access
Characterization of the host&amp;ndash;guest complex of a curcumin analog with &amp;beta;-cyclodextrin and &amp;beta;-cyclodextrin&amp;ndash;gemini surfactant and evaluation of its anticancer activity
International Journal of Nanomedicine·2015· 21 citedOpen Access
The development and assessment of high‐throughput mass spectrometry‐based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate
Journal of Mass Spectrometry·2014· 19 cited
Multi‐stage tandem mass spectrometric analysis of novel β‐cyclodextrin‐substituted and novel bis‐pyridinium gemini surfactants designed as nanomedical drug delivery agents
Rapid Communications in Mass Spectrometry·2014· 18 cited
Dicationic gemini nanoparticle design for gene therapy
2013· 5 cited
A general liquid chromatography tandem mass spectrometry method for the quantitative determination of diquaternary ammonium gemini surfactant drug delivery agents in mouse keratinocytes’ cellular lysate
Journal of Chromatography A·2013· 21 cited
Development of Lyophilized Gemini Surfactant-Based Gene Delivery Systems: Influence of Lyophilization on the Structure, Activity and Stability of the Lipoplexes
Journal of Pharmacy & Pharmaceutical Sciences·2012· 26 citedOpen Access
BAJ volume 17 issue 3 Cover and Back matter
British Actuarial Journal·2012Open Access
Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma
European Journal of Pharmaceutics and Biopharmaceutics·2012· 47 cited
page 1 of 9Next →

Frequent Co-authors

Shawn Wettig(16), Marianna Földvári(13), Ildikó Badea(12), Ronald P. Steer(6), Lee D. Wilson(5), B. E. Conway(4), R. G. Sutherland(4), Jagbir Singh(4), Chandra M. Sehgal(3), David R. Demmer(3), McDonald Donkuru(3), Chuanzhong Wang(3), Xingfu Li(3), Déborah Michel(3), Jacques E. Desnoyers(2), Alan Rosenberg(2), Douglas R. James(2), Mohammad Iqbal(2), Andrzej Maciejewski(2), Ali Safarzadeh–Amiri(2)